Summary

Eligibility
for people ages 18-65 (full criteria)
Healthy Volunteers
healthy people welcome
Location
at Los Angeles, California and other locations
Dates
study started
completion around
Principal Investigator
by Reza Tadayon-nejad, MD PhD

Description

Summary

This study investigates the computational mechanisms associated with psychiatric disease dimensions. The study will characterize the relationship between computational parameter estimates of task performance and psychiatric symptoms and diagnoses with a longitudinal approach over a 12 month interval. Participants will be healthy participants recruited through Prolific an on-line crowdsourcing service, and psychiatric patients and healthy participants recruited via UCLA Psychiatry Clinics and UCLA's STAND Program

Official Title

Leveraging Computationally Derived Measures of Individual Differences in Learning and Decision-making to Predict Psychiatric Diagnosis, Symptoms and Changes in Symptom Severity Across Time

Details

The goal of computational psychiatry is to gain knowledge about underlying neurocomputational processes that underpin psychiatric disorders and to leverage this knowledge for improving diagnosis and treatment. A key step toward achieving this goal is to develop measures of individual differences in computations obtained from a single individual that are reliable, robust and meaningfully relevant to psychiatric dysfunction. In order to attain these objectives, it is essential we substantiate relationships between candidate computational mechanisms and diagnostic categories, symptom dimensions and treatment outcomes. In the present study, a computational assessment task battery (CAB) will be utilized that is designed to measure individual differences across a multidimensional array of computational processes. The study aims to separate three different variance components contributing to variability in computational parameter estimation: occasion-related variance due to incidental day to day changes in task performance, state-dependent variance that is related to meaningful variation across time in the underlying computations within an individual, and trait-related differences pertaining to stable individual differences in computations across individuals. To accomplish this, repeated assessments will be implemented using this battery across a 1-year interval within an on-line sample, and use hierarchical Bayesian modeling to separate the effect of occasion, state and trait-related variance on these parameter estimates. These variance components will then be related to diagnostic categories, symptom dimensions and symptom severity measures in a diverse cohort of psychiatric patients (mostly with depression, anxiety and OCD) recruited in Southern California. Finally, the relationship will be tracked between the computational parameter estimates and changes in symptoms across time in a subset of these patients. This study promises to significantly advance understanding of how to reliably extract diagnostically relevant computationally-derived measures of cognitive phenotypes that could eventually be migrated to the clinic.

Keywords

Behavior, Depressive Disorder, Anxiety Disorders, Obsessive Compulsive Disorder (OCD), Computational Psychiatry, Behavioral task battery, Obsessive-Compulsive Disorder, Behavioral task performance

Eligibility

You can join if…

Open to people ages 18-65

(healthy control participants):

  • Age range of 18 to 65.
  • Not currently having a psychiatric diagnosis determined after psychiatric evaluation by Drs. Tadayon-Nejad and Wei (both are board certified psychiatrists).
  • Ability to understand and perform experimental tasks, i.e. basic ability to communicate and comprehend tasks.
  • Ability to give informed consent.

You CAN'T join if...

(healthy control participants):

• Prior history and or current diagnosis of neurological disease.

Inclusion criteria (patients):

  • Age range of 18 to 65.
  • Psychiatric diagnosis of any type of depressive disorders, any type of anxiety disorders or obsessive-compulsive disorder.
  • Primary or comorbid bipolar disorders are allowed but only if not in the acute manic phase.
  • Comorbidity with autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD) are allowed.
  • Ability to understand and perform experimental tasks, i.e. basic ability to communicate and comprehend tasks.
  • Ability to give informed consent.

Exclusion criteria (patients):

Locations

  • UCLA Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles
    Los Angeles California 90095 United States
  • California Insitute of Technology
    Pasadena California 91125 United States

Lead Scientist at UCLA

  • Reza Tadayon-nejad, MD PhD
    HS Assistant Clinical Professor, Psychiatry and Biobehavioral Sciences, Medicine. Authored (or co-authored) 5 research publications

Details

Status
not yet accepting patients
Start Date
Completion Date
(estimated)
Sponsor
California Institute of Technology
ID
NCT06705179
Study Type
Interventional
Participants
Expecting 1100 study participants
Last Updated